Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT05331209

Acupuncture With/Without Self-acupressure for Post-oophorectomy Hot Flashes in BRCA Carriers

Acupuncture With or Without Self-acupressure for Hot Flashes in Post-oophorectomy Patients With BRCA Mutations: A Prospective, Randomized Controlled Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Shaare Zedek Medical Center · Academic / Other
Sex
Female
Age
25 Years
Healthy volunteers
Not accepted

Summary

Risk-reducing surgery with salpingo-oophorectomy (RRSO) is the standard recommended treatment for all female carriers of BRCA genes 1 and 2. The post-surgical menopause induced is invariably accompanied by hot flashes and other symptoms, which can severely impair quality of life and function. Hormone-replacement therapy (HRT) is the standard conventional treatment for these symptoms, though these drugs do not always provide adequate relief and many patients either cannot receive them due to a diagnosis of breast cancer or hypercoagulable state; or are unwilling to take them due to their concern about the associated increased risk for developing hormone-induced breast cancer. Acupuncture and acupressure have been researched extensively and shown to be both safe and effective in reducing hot flashes in post-menopausal patients and in those with breast cancer receiving anti-hormonal drugs. The present study will examine the effectiveness of acupuncture, with/without self-acupressure, on 200 post- RRSO patients who suffer from at least 5 hot flashes per day, including those treated with HRT. All participants will receive 8 weekly treatments with acupuncture, and then randomly assigned to receive (or not) self-administered acupressure, to be performed daily at home. The response to the study interventions will be assessed using daily Hot Flash Scores, the Menopause Specific Quality of Life (MenQoL) and Measure Yourself Concerns and Wellbeing (MYCAW) questionnaires (at baseline; at the end of the 8-week intervention; and at 16 weeks). The safety of the study treatments will be assessed throughout.

Conditions

Interventions

TypeNameDescription
OTHERAcupunctureWeekly acupuncture treatments, for 8 weeks (8 treatments)
OTHERAcupuncture-AcupressureWeekly acupuncture, for 8 weeks, with daily self-acupressure by the patient at home.

Timeline

Start date
2026-01-01
Primary completion
2027-12-31
Completion
2027-12-31
First posted
2022-04-15
Last updated
2025-05-16

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT05331209. Inclusion in this directory is not an endorsement.